2012
DOI: 10.4261/1305-3825.dir.5923-12.2
|View full text |Cite
|
Sign up to set email alerts
|

Inversion time prolongation at late enhancement cardiac magnetic resonance in a myeloma patient

Abstract: A patient undergoing chemotherapy for multiple myeloma had a sudden onset of heart failure. Cardiac magnetic resonance was performed after echocardiography to rule out myocardial late enhancement, which was not detected. Interestingly, the inversion time of the T1-weighted inversion recovery late enhancement sequence needed to be significantly increased (from the usual 250-300 to 490 ms) to obtain diagnostic images. This report presents the clinical case of this patient, and discusses potential implications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…T1 mapping makes it possible to bypass windowing and signal enhancement variations by calculating T1 relaxation times directly, compared to DE images. This in turn permits signal quantification (in milliseconds) of each myocardial voxel and subsequent standardized characterization of myocardial tissue (5).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…T1 mapping makes it possible to bypass windowing and signal enhancement variations by calculating T1 relaxation times directly, compared to DE images. This in turn permits signal quantification (in milliseconds) of each myocardial voxel and subsequent standardized characterization of myocardial tissue (5).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, with conventional DE-MRI sequences, signal intensity is expressed on an arbitrarily scale that differs from one imaging to another. Therefore, this method is not suitable for direct signal quantification (5). Furthermore, concerns about the increased risk of gadolinium-induced nephrogenic systemic fibrosis have increased gradually in populations with impaired renal function (6,7).…”
mentioning
confidence: 99%